Comparison of the effect of LPS and PAM3 on ventilated lungs

Hans P Hauber1, Dörte Karp, Torsten Goldmann

  • 1Pathophysiology of Inflammation, Research Center Borstel, Borstel, Germany. hphauber@fz-borstel.de

BMC Pulmonary Medicine
|April 21, 2010
PubMed
Abstract

Insights

Lipopeptide PAM3 from Gram-positive bacteria, like LPS, enhances ventilator-induced lung inflammation. PAM3 also increases pulmonary resistance in mechanically ventilated mice, unlike LPS.

Area of Science:

  • Pulmonary inflammation research
  • Microbiology and immunology
  • Mechanical ventilation studies

Background:

  • Lipopolysaccharide (LPS) from Gram-negative bacteria is known to worsen lung inflammation during mechanical ventilation.
  • The impact of Gram-positive bacterial components on ventilated lungs remains largely uncharacterized.

Purpose of the Study:

  • To investigate the effects of lipopolysaccharide (LPS) and a lipopeptide (PAM3) from Gram-positive bacteria on mechanically ventilated lungs.
  • To compare the inflammatory and functional responses induced by LPS and PAM3 in a mouse model.

Main Methods:

  • Mechanical ventilation was applied to C57/Bl6 mice.
  • Intratracheal administration of sterile saline (sham), LPS (1-5 microg), and PAM3 (50-200 nM).
  • Measurement of lung function (resistance, compliance), inflammatory markers (MIP-2, TNFalpha mRNA), and neutrophil influx.

Main Results:

  • Mechanical ventilation alone increased resistance and decreased compliance.
  • PAM3 significantly increased pulmonary resistance, whereas LPS did not.
  • Both LPS and PAM3 elevated MIP-2 and TNFalpha mRNA expression.
  • Neutrophil influx was significantly increased by both LPS (at 5 microg) and PAM3 (at both concentrations).

Conclusions:

  • PAM3, similar to LPS, exacerbates ventilator-induced lung inflammation.
  • PAM3 uniquely increases pulmonary resistance in ventilated lungs, distinguishing it from LPS.
  • Further research is needed to elucidate the role of lipopeptides in ventilator-associated lung injury (VALI).